Table III.
GRADE assessment of outcomes.
| Outcome | Quality assessment | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | Quality | Importance | |
| VAS-1 | 3 | RCT | Not serious | No serious inconsistenc | No serious indirectness | No serious imprecision | Undetected | High | Critical |
| VAS-2 | 2 | RCT | Not serious | No serious inconsistency | No serious indirectness | No serious imprecision | Undetected | High | Critical |
| VAS-3 | 3 | RCT | Not serious | Seriousa | No serious indirectness | No serious imprecision | Undetected | Moderate | Critical |
| PFT | 2 | RCT | Not serious | Seriousa | No serious indirectness | No serious imprecision | Undetected | Moderate | Important |
a
The heterogeneity among included studies was not negligible. RCT, randomization controlled trial; VAS-1, visual analogue score at one month; PFT, plantar fascia thickness; GRADE, Grading of Recommendations Assessment, Development and Evaluation.